Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Pfizer
Scientific Title
Phase 1/2 Study Of PF-06463922 (An ALK/ROS1 Tyrosine Kinase Inhibitor) In Patients With Advanced Non-Small Cell Lung Cancer Harboring Specific Molecular Alterations